I 

118TH CONGRESS 

2D SESSION H. R. 9039 

To require the Interagency Working Group on Toxic Exposure to conduct 

research on the diagnosis and treatment of health conditions of descendants of individuals exposed to toxic substances while serving as members 

of the Armed Forces, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 15, 2024 

Mrs. DINGELL introduced the following bill; which was referred to the 

Committee on Veterans’ Affairs 

A BILL 

To require the Interagency Working Group on Toxic Exposure to conduct research on the diagnosis and treatment 

of health conditions of descendants of individuals exposed 

to toxic substances while serving as members of the 

Armed Forces, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Molly R. Loomis Re5 search for Descendants of Toxic Exposed Veterans Act of 

6 2024’’. 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 9039 IH

1 SEC. 2. RESEARCH ON DIAGNOSIS AND TREATMENT OF 

2 HEALTH CONDITIONS OF DESCENDANTS OF 

3 INDIVIDUALS EXPOSED TO TOXIC SUB4 STANCES WHILE SERVING IN ARMED FORCES. 

5 (a) IN GENERAL.—Subsection (b) of section 501 of 

6 the Sergeant First Class Heath Robinson Honoring our 

7 Promise to Address Comprehensive Toxics Act of 2022 

8 (Public Law 117–168) is amended by adding at the end 

9 the following new paragraph: 

10 ‘‘(3) Establish Federal interagency task forces 

11 to conduct collaborative research activities.’’. 

12 (b) REPORTING.—Subsection (c) of such section is 

13 amended by striking paragraphs (2) and (3) and inserting 

14 the following: 

15 ‘‘(2) Not later than two years after the date of 

16 the enactment of this Act— 

17 ‘‘(A) a report containing a description of 

18 the collaborative research activities identified by 

19 the Working Group under subsection (b); 

20 ‘‘(B) the findings of the members of the 

21 Working Group with respect to the collaborative 

22 research activities described in subparagraph 

23 (A); 

24 ‘‘(C) the strategic plan developed, by the 

25 Working Group under subsection (b); and 


ssavage on LAPJG3WLY3PROD with BILLS
3 

•HR 9039 IH

1 ‘‘(D) such recommendations as the Work2 ing Group may have for legislative or adminis3 trative action to improve collaborative research 

4 activities among the members of the Working 

5 Group. 

6 ‘‘(3) Not less frequently than annually during 

7 the five-year period covered by the strategic plan de8 veloped under subsection (b)— 

9 ‘‘(A) a summary of the collaborative re10 search activities carried out by the members of 

11 the Working Group and the findings of the 

12 members with respect to such research activi13 ties; 

14 ‘‘(B) a progress report on implementation 

15 of the strategic plan developed by the Working 

16 Group under subsection (b); and 

17 ‘‘(C) such recommendations as the Work18 ing Group may have for legislative or adminis19 trative action to improve collaborative research 

20 activities among members of the Working 

21 Group.’’. 

22 (c) RESEARCH REQUIREMENTS.—Such section is 

23 amended— 

24 (1) by redesignating subsections (c) through (e) 

25 as subsections (d) through (f), respectively; 


ssavage on LAPJG3WLY3PROD with BILLS
4 

•HR 9039 IH

1 (2) in subsection (e), as redesignated by para2 graph (1), by striking ‘‘under subsection (c)’’ and 

3 inserting ‘‘under subsection (d)’’; and 

4 (3) by inserting after subsection (b) the fol5 lowing new subsection (c): 

6 ‘‘(c) REQUIREMENTS RELATING TO CERTAIN RE7 SEARCH ON IMPACTS TO DESCENDANTS.—The Working 

8 Group and the Agency for Toxic Substances and Disease 

9 Registry shall— 

10 ‘‘(1) establish an interagency task force to con11 duct research on the diagnosis and treatment of 

12 health conditions of descendants of toxic-exposed 

13 veterans (as defined in section 101 of title 38, 

14 United States Code); and 

15 ‘‘(2) maintain a publicly available website with 

16 information on the activities and findings of the 

17 Agency under subparagraph (A), including a review 

18 of all relevant data to determine the strength of evi19 dence for a positive association between a health 

20 condition researched and a toxic exposure risk activ21 ity (as defined in section 1710(e)(4) of title 38, 

22 United States Code) based on the categories set 

23 forth under section 1173(c)(2) of title 38, United 

24 States Code.’’. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS